Loading Page
Dr. Janet M. Yoon, MD is a pediatric oncologist in DUARTE, CA specializing in pediatric hematology/oncology and general pediatrics. She graduated from University of Toledo College of Medicine in 2000 and has 26 years of experience.
Dr. Janet M. Yoon, MD graduated from University of Toledo College of Medicine in 2000. She is certified by the American Board of Pediatrics: Pediatric Hematology-Oncology and has a state license in California.
Medical School: University of Toledo College of Medicine (2000)
Board Certification: American Board of Pediatrics: Pediatric Hematology-Oncology
Licensed In: California
Dr. Janet M. Yoon, MD does not have any reviews yet, be the first to leave a review of Dr. Janet M. Yoon, MD here: Leave a Review
These charts describe general payments received by Dr. Janet M. Yoon, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$7,768
Non-Covered $7,628 |
Vitrakvi $140 |
|||||
|
$1,184
Non-Covered Product $1,184 |
||||||
|
$207
QINLOCK $207 |
||||||
|
$144
Defitelio $91 |
RYLAZE $39 |
Erwinaze $13 |
||||
|
$138
KYMRIAH $123 |
ADAKVEO $16 |
|||||
|
$229
Non-Covered Product $74 |
Oncaspar $38 |
MONJUVI $26 |
Ruconest $26 |
Blincyto $24 |
Other $41 |
| $7,000 | |
| $1,184 | |
| $1,130 | |
| $357 |
Dr. Janet M. Yoon, MD has received 48 research payments totaling $701,906.
Janet Yoon, MD, is a pediatric hematologist-oncologist in the Los Angeles area who pursued a career treating childhood cancer because it allows her to build long-term relationships with her young patients and their caregivers. Inspired by their resilience and strength, she stays at the leading edge of her field so that she can introduce families to the latest therapies, specifically those that minimize harmful and long-lasting side effects. As medical director of the Pediatric Musculoskeletal Tumor Program at City of Hope® Cancer Center Duarte, Dr Yoon sees children, adolescents and young adults with a wide range of conditions, including sarcoma and pediatric solid tumors.
